A Scaffold Protein, AHNAK1, Is Required for Calcium Signaling during T Cell Activation

Engagement of the T cell antigen receptor (TCR) during antigen presentation initiates a coordinated action of a large number of signaling proteins and ion channels. AHNAK1 is a scaffold protein, highly expressed by CD4 + T cells, and is a critical component for calcium signaling. We showed that AHNA...

Full description

Saved in:
Bibliographic Details
Published in:Immunity (Cambridge, Mass.) Vol. 28; no. 1; pp. 64 - 74
Main Authors: Matza, Didi, Badou, Abdallah, Kobayashi, Koichi S., Goldsmith-Pestana, Karen, Masuda, Yutaka, Komuro, Akihiko, McMahon-Pratt, Diane, Marchesi, Vincent T., Flavell, Richard A.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-01-2008
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Engagement of the T cell antigen receptor (TCR) during antigen presentation initiates a coordinated action of a large number of signaling proteins and ion channels. AHNAK1 is a scaffold protein, highly expressed by CD4 + T cells, and is a critical component for calcium signaling. We showed that AHNAK1-deficient mice were highly susceptible to Leishmania major infection. AHNAK1-deficient CD4 + T cells responded poorly to TCR stimulation in vitro with low proliferation and low Interleukin-2 production. Furthermore, AHNAK1 deficiency resulted in a reduced calcium influx upon TCR crosslinking and subsequent poor activation of the transcription factor NFAT. AHNAK1 was required for plasma membrane expression of L-type calcium channels α1S (Ca v1.1), probably through its interaction with the β regulatory subunit. Thus, AHNAK1 plays an essential role in T cell Ca 2+ signaling through Ca v1 channels, triggered via TCR activation; therefore, AHNAK1 is a potential target for therapeutic intervention.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
These authors contributed equally to this work.
Present address : Université Cadi Ayyad, Faculté polydisciplinaire Safi, Sidi Bouzid, B.P. 4162, 46000 Safi, Morocco
ISSN:1074-7613
1097-4180
DOI:10.1016/j.immuni.2007.11.020